i2o Therapeutics

Oral Biologics

i2o Therapeutics is a biotechnology company that is developing a new class of biologics that can be delivered orally. The company's technology uses ionic liquids, which are a type of liquid salt that is stable at room temperature. Ionic liquids have the potential to deliver biologics more effectively and safely than traditional methods, such as injections. i2o Therapeutics is currently developing its technology for the treatment of metabolic and inflammatory diseases.